Is the family history positive for SLE a predisposing factor for anti-TNFalpha blockers induced lupus? A case report.
Caramaschi
Paola
P
Ravagnani
Viviana
V
Bambara
Lisa Maria
LM
Biasi
Domenico
D
D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D000069285:Infliximab; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000453:epidemiology / Q000235:genetics*; D011565:Psoriasis / Q000188:drug therapy* / Q000453:epidemiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab